Association of Allostatic Load With All-Cause Mortality in Patients With Breast Cancer
JAMA Network Open · 18.05.2023 · 6 (5) · e2313989
DOI: 10.1001/jamanetworkopen.2023.13989 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 18.05.2023. Verfasst von Samilia Obeng-Gyasi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus. Hauptthemen laut MEDLINE: Breast Neoplasms, Allostasis. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Importance Elevated allostatic load (AL) has been associated with adverse socioenvironmental stressors and tumor characteristics that convey poor prognosis in patients with breast cancer. Currently, the association between AL and all-cause mortality in patients with breast cancer is unknown.
Objective
To examine the association between AL and all-cause mortality in patients with breast cancer. Design, Setting, and Participants This cohort study used data from an institutional electronic medical record and cancer registry at the National Cancer Institute Comprehensive Cancer Center. Participants were patients with breast cancer diagnoses (stage I-III) between January 1, 2012, through December 31, 2020. Data were analyzed from April 2022 through November 2022. Exposure AL was expressed as a summary score calculated by assigning 1 point for biomarkers in the worst sample quartile. High AL was defined as AL greater than the median. Main Outcomes and Measures The main outcome was all-cause mortality. A Cox proportional hazard models with robust variance tested the association between AL and all-cause mortality.
Results
There were 4459 patients (median [IQR] age, 59 [49-67] years) with an ethnoracial distribution of 3 Hispanic Black patients (0.1%), 381 non-Hispanic Black patients (8.5%), 23 Hispanic White patients (0.5%), 3861 non-Hispanic White patients (86.6%), 27 Hispanic patients with other race (0.6%), and 164 non-Hispanic patients with other race (3.7%). The mean (SD) AL was 2.6 (1.7). Black patients (adjusted relative ratio [aRR], those with 1.11; 95% CI, 1.04-1.18), single marital status (aRR, 1.06; 95% CI, 1.00-1.12), and those with government-supplied insured (Medicaid aRR, 1.14; 95% CI, 1.07-1.21; Medicare aRR, 1.11; 95% CI, 1.03-1.19) had a higher adjusted mean AL than those who were White, married/living as married, or privately insured, respectively. Adjusting for sociodemographic, clinical, and treatment factors, high AL was associated with a 46% increase in mortality risk (hazard ratio [HR], 1.46; 95% CI, 1.11-1.93) over low AL. Similarly, compared with patients in the first AL quartile, those in the third quartile (HR, 1.53; 95% CI, 1.07-2.18) and the fourth quartile (HR, 1.79; 95% CI, 1.16-2.75) had significantly increased risks of mortality. There was a significant dose-dependent association between increased AL and a higher risk of all-cause mortality. Furthermore, AL remained significantly associated with higher all-cause mortality after adjusting for the Charlson Comorbidity Index. Conclusions and Relevance These findings suggest increased AL is reflective of socioeconomic marginalization and associated with all-cause mortality in patients with breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus.
- Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus.
- Secondary Data Core, Center for Biostatistics, College of Medicine, The Ohio State University, Columbus.
- Department of Medicine, Indiana University School of Medicine, Indianapolis.
- Department of Psychology, The Ohio State University, Columbus.
Förderung
- NCI NIH HHS
Zitieren
APA
Obeng-Gyasi, S., Elsaid, M. I., Lu, Y., Chen, J. C., Carson, W. E., Ballinger, T. J., & Andersen, B. L. (2023). Association of Allostatic Load With All-Cause Mortality in Patients With Breast Cancer. JAMA Network Open, 6(5), e2313989. https://doi.org/10.1001/jamanetworkopen.2023.13989
Vancouver
Obeng-Gyasi S, Elsaid MI, Lu Y, Chen JC, Carson WE, Ballinger TJ, et al. Association of Allostatic Load With All-Cause Mortality in Patients With Breast Cancer. JAMA Network Open. 2023;6(5):e2313989. doi:10.1001/jamanetworkopen.2023.13989
BibTeX
@article{ObengGyasi2023,
author = {Obeng-Gyasi, Samilia and Elsaid, Mohamed I and Lu, Yurong and Chen, J C and Carson, William E and Ballinger, Tarah J and Andersen, Barbara L},
title = {Association of Allostatic Load With All-Cause Mortality in Patients With Breast Cancer},
journal = {JAMA Network Open},
year = {2023},
volume = {6},
number = {5},
pages = {e2313989},
doi = {10.1001/jamanetworkopen.2023.13989}
}
EUVIMED